Clinical Trial Update: Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of SR121463B in patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH) and hyponatremia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• SR121463B

Snippet

Sponsor: Sanofi | Conditions: Inappropriate ADH Syndrome, Hyponatremia | Phase 3 | Status: COMPLETED